PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Novo Nordisk A/S (NVO)

Equity · Currency in USD · Last updated Dec 2, 2023

Novo Nordisk A/S is a global healthcare company based in Denmark, specializing in the research, development, and manufacturing of pharmaceutical products. The company is a leader in diabetes care and is also involved in areas such as hemophilia care, growth hormone therapy, and hormone replacement therapy. Additionally, Novo Nordisk produces the successful weight loss drug, Wegovy.

SummaryFinancials

Company Info

ISINUS6701002056
CUSIP670100205
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$451.71B
EPS$2.46
PE Ratio41.17
PEG Ratio5.25
Revenue (TTM)$214.49B
Gross Profit (TTM)$148.51B
EBITDA (TTM)$100.11B
Year Range$61.29 - $105.69
Target Price$103.55
Short %0.14%
Short Ratio1.31

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Novo Nordisk A/S, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
28.65%
7.29%
NVO (Novo Nordisk A/S)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with NVO

Novo Nordisk A/S

Popular comparisons: NVO vs. LLY, NVO vs. NVS, NVO vs. MRK, NVO vs. POST, NVO vs. VTI, NVO vs. AAPL, NVO vs. VXUS, NVO vs. XLV, NVO vs. VYM, NVO vs. XLF

Return

Novo Nordisk A/S had a return of 51.09% year-to-date (YTD) and 62.13% in the last 12 months. Over the past 10 years, Novo Nordisk A/S had an annualized return of 22.46%, outperforming the S&P 500 benchmark which had an annualized return of 9.87%.


PeriodReturnBenchmark
Year-To-Date51.09%19.67%
1 month2.78%8.42%
6 months28.65%7.29%
1 year62.13%12.71%
5 years (annualized)37.57%10.75%
10 years (annualized)22.46%9.87%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-3.97%0.86%-0.46%16.00%-2.01%6.19%5.46%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
NVO
Novo Nordisk A/S
2.11
^GSPC
S&P 500
0.91

Sharpe Ratio

The current Novo Nordisk A/S Sharpe ratio is 2.11. A Sharpe ratio higher than 2.0 is considered very good.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JulyAugustSeptemberOctoberNovemberDecember
2.11
0.91
NVO (Novo Nordisk A/S)
Benchmark (^GSPC)

Dividend History

Novo Nordisk A/S granted a 0.73% dividend yield in the last twelve months. The annual payout for that period amounted to $0.74 per share.


PeriodTTM20222021202020192018201720162015201420132012
Dividend$0.74$0.57$0.52$0.46$0.44$0.45$0.41$0.52$0.27$0.30$0.23$0.18

Dividend yield

0.73%0.84%0.94%1.33%1.51%1.97%1.52%2.87%0.92%1.43%1.23%1.12%

Monthly Dividends

The table displays the monthly dividend distributions for Novo Nordisk A/S. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023$0.00$0.00$0.42$0.00$0.00$0.00$0.00$0.31$0.00$0.00$0.00
2022$0.00$0.00$0.37$0.00$0.00$0.00$0.00$0.20$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.33$0.00$0.00$0.00$0.00$0.19$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.28$0.00$0.00$0.00$0.00$0.18$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.28$0.00$0.00$0.00$0.00$0.16$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.29$0.00$0.00$0.00$0.00$0.16$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.24$0.00$0.00$0.00$0.00$0.17$0.00$0.00$0.00$0.00
2016$0.00$0.00$0.35$0.00$0.00$0.00$0.00$0.17$0.00$0.00$0.00$0.00
2015$0.00$0.00$0.27$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2014$0.00$0.00$0.30$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2013$0.00$0.00$0.23$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2012$0.18$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Dividend Yield & Payout


Dividend Yield
NVO
0.73%
Market bottom
1.03%
Market top
5.13%
Novo Nordisk A/S has a dividend yield of 0.73%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
NVO
1.98%
Market bottom
17.93%
Market top
59.27%
Novo Nordisk A/S has a payout ratio of 1.98%, which is below the market average. This means Novo Nordisk A/S returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-4.79%
-4.21%
NVO (Novo Nordisk A/S)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Novo Nordisk A/S. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Novo Nordisk A/S was 70.97%, occurring on Oct 26, 1984. Recovery took 1720 trading sessions.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-70.97%Sep 23, 1983278Oct 26, 19841720Aug 26, 19911998
-45.44%Aug 4, 2015332Nov 23, 2016287Jan 17, 2018619
-44.8%Apr 2, 200288Aug 5, 2002161Mar 26, 2003249
-42.51%Apr 7, 1998241Mar 22, 19993Mar 25, 1999244
-40.96%Apr 9, 2008231Mar 9, 2009104Aug 5, 2009335

Volatility Chart

The current Novo Nordisk A/S volatility is 8.48%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
8.48%
2.79%
NVO (Novo Nordisk A/S)
Benchmark (^GSPC)